[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[S. 709 Introduced in Senate (IS)]
<DOC>
116th CONGRESS
1st Session
S. 709
To establish an interactive dashboard to allow the public to review
information on the price and utilization of prescription drugs
purchased by Federal programs.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
March 7, 2019
Mr. Casey (for himself and Ms. Collins) introduced the following bill;
which was read twice and referred to the Committee on Health,
Education, Labor, and Pensions
_______________________________________________________________________
A BILL
To establish an interactive dashboard to allow the public to review
information on the price and utilization of prescription drugs
purchased by Federal programs.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Prescription Drug Pricing Dashboard
Act''.
SEC. 2. PRESCRIPTION DRUG PRICING DASHBOARD.
(a) In General.--The Secretary of Health and Human Services
(referred to in this section as the ``Secretary'') shall establish, and
annually update, an interactive internet website-based dashboard,
through which patients, clinicians, researchers, and the public can
review information on the price and utilization of prescription drugs
purchased by Federal programs, and view pricing trends over time.
(b) Content.--
(1) General information.--The internet website established
under subsection (a) shall provide at least the following
information with respect to a drug:
(A) The brand and generic name.
(B) Consumer-friendly information of the drug's
uses and other relevant clinical information.
(C) The manufacturer.
(D) For each Federal program (which shall include
the Medicare program under title XVIII of the Social
Security Act (42 U.S.C. 1395 et seq.), the Medicaid
program under title XIX of the Social Security Act (42
U.S.C. 1396 et seq.), the Federal Employees Health
Benefits Program established under chapter 89 of title
5, United States Code, and any other Federal program,
as determined by the Secretary), the following
information regarding program spending for each drug:
(i) The average Federal and, as applicable
State, spending per dosage unit in the
preceding 2 fiscal years.
(ii) The percentage change in spending on
the drug per dosage unit from the preceding
year, and to the extent feasible, from the
preceding 5 to 10 fiscal years.
(iii) The change in average spending per
dosage unit in the preceding 2 fiscal years.
(iv) The annual growth rate in average
spending per dosage unit in the preceding 5
fiscal years.
(v) Total spending for the preceding fiscal
year.
(vi) The number of individuals receiving
such drug under the program in the preceding
fiscal year.
(vii) Average spending on the drug per
beneficiary for the preceding fiscal year.
(viii) With respect to a drug covered under
part B of such title XVIII the average sales
price as determined under section 1847A of the
Social Security Act (42 U.S.C. 1395w-3a) for
the preceding fiscal year.
(ix) Consumer-friendly information about
the average, highest, and lowest out-of-pocket
cost for the drug (such as copayment or
coinsurance amounts) for an individual enrolled
in a State plan under such title XIX or the
Medicare program under such title XVIII
(including parts B and D of such title) in the
preceding fiscal year or in the preceding plan
year in the case of part D of such title,
including such costs under such part before,
during, and after the coverage gap described in
subparagraphs (C) and (D) section 1860D-2(b)(2)
of the Social Security Act (42 U.S.C. 1395w-
102(b)(2)).
(x) Such additional information pertaining
to Federal expenditures on, or consumer out-of-
pocket costs for, drugs, as the Secretary
determines appropriate.
(2) Highlighted drugs.--The Secretary shall identify, in a
separate element of the dashboard--
(A) for each Federal program described in paragraph
(1)(D), the 15 drugs with the highest total program
spending, including, for drugs covered under the
Medicaid program, the median State spending per dosage
unit;
(B) the 15 drugs with the highest total Federal
spending across all such Federal programs;
(C) any drugs with annual per-user spending under
any such program, based on claims data analysis, that,
for the first reporting year is $10,000 or more per
user, and, in subsequent reporting years, is priced at
or above the rate, as determined by the Secretary, that
is $10,000, increased by the medical care consumer
price index; and
(D) the drugs ranked among the top 10 highest unit
costs increases (if not already identified) for any
such Federal program.
(3) Data files.--The interactive internet website-based
dashboard described in this subsection shall include machine-
readable data files.
(4) Additional information.--The Secretary may include such
additional information (not otherwise prohibited in law from
being disclosed) on the website-based dashboard that would
provide patients, clinicians, researchers, and the public with
information about prescription drugs and their prices as the
Secretary determines appropriate.
(c) Plan To Incorporate Data From Other Programs.--
(1) Expansion of dashboard.--Within 2 years of the date of
enactment of the Prescription Drug Pricing Dashboard Act, the
Secretary shall submit to the Committee on Finance, the
Committee on Health, Education, Labor, and Pensions, the
Committee on Armed Services, the Committee on Veterans'
Affairs, and the Special Committee on Aging of the Senate and
the Committee on Ways and Means, the Committee on Energy and
Commerce, the Committee on Armed Services, and the Committee on
Veterans' Affairs of the House of Representatives, a report
that includes a plan to expand the dashboard under this section
to include data on Federal expenditures on, and patient out-of-
pocket costs for, drugs under the TRICARE program, the health
program of the Department of Veterans Affairs, and qualified
health plans purchased through an American Health Benefits
Exchange or other private health insurance coverage.
(2) Consultation.--In preparing the report in paragraph
(1), the Secretary shall consult with the Secretary of Defense
and the Secretary of Veterans Affairs.
<all>
Prescription Drug Pricing Dashboard Act
#709 | S Congress #116
Policy Area: Health
Last Action: Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (3/7/2019)
Bill Text Source: Congress.gov
Summary and Impacts
Original Text